A folate receptor-targeted liposomal formulation for paclitaxel
- 1 June 2006
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 316 (1-2), 148-153
- https://doi.org/10.1016/j.ijpharm.2006.02.027
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinomaCancer Letters, 2004
- Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapyAdvanced Drug Delivery Reviews, 2004
- Tocol emulsions for drug solubilization and parenteral deliveryAdvanced Drug Delivery Reviews, 2004
- Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptorAdvanced Drug Delivery Reviews, 2004
- Strategy for the treatment of acute myelogenous leukemia based on folate receptor β–targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acidBlood, 2002
- Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivoJournal of Controlled Release, 1997
- Binding of Taxol to Plastic and Glass Containers and Protein under in Vitro ConditionsJournal of Pharmaceutical Sciences, 1996
- Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- PaclitaxelDrugs, 1994
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990